These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 11953745)
1. Segregation at three loci explains familial and population risk in Hirschsprung disease. Gabriel SB; Salomon R; Pelet A; Angrist M; Amiel J; Fornage M; Attié-Bitach T; Olson JM; Hofstra R; Buys C; Steffann J; Munnich A; Lyonnet S; Chakravarti A Nat Genet; 2002 May; 31(1):89-93. PubMed ID: 11953745 [TBL] [Abstract][Full Text] [Related]
2. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Angrist M; Bolk S; Halushka M; Lapchak PA; Chakravarti A Nat Genet; 1996 Nov; 14(3):341-4. PubMed ID: 8896568 [TBL] [Abstract][Full Text] [Related]
3. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Salomon R; Attié T; Pelet A; Bidaud C; Eng C; Amiel J; Sarnacki S; Goulet O; Ricour C; Nihoul-Fékété C; Munnich A; Lyonnet S Nat Genet; 1996 Nov; 14(3):345-7. PubMed ID: 8896569 [TBL] [Abstract][Full Text] [Related]
4. Familial form of hirschsprung disease: nucleotide sequence studies reveal point mutations in the RET proto-oncogene in two of six families but not in other candidate genes. Munnes M; Fanaei S; Schmitz B; Muiznieks I; Holschneider AM; Doerfler W Am J Med Genet; 2000 Sep; 94(1):19-27. PubMed ID: 10982477 [TBL] [Abstract][Full Text] [Related]
5. Hirschsprung, RET-SOX and beyond: the challenge of examining non-mendelian traits (Review). Pusch CM; Sasiadek MM; Blin N Int J Mol Med; 2002 Oct; 10(4):367-70. PubMed ID: 12239580 [TBL] [Abstract][Full Text] [Related]
6. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. Hofstra RM; Wu Y; Stulp RP; Elfferich P; Osinga J; Maas SM; Siderius L; Brooks AS; vd Ende JJ; Heydendael VM; Severijnen RS; Bax KM; Meijers C; Buys CH Hum Mutat; 2000; 15(5):418-29. PubMed ID: 10790203 [TBL] [Abstract][Full Text] [Related]
7. Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus. Edery P; Pelet A; Mulligan LM; Abel L; Attié T; Dow E; Bonneau D; David A; Flintoff W; Jan D J Med Genet; 1994 Aug; 31(8):602-6. PubMed ID: 7815416 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease. Gath R; Goessling A; Keller KM; Koletzko S; Coerdt W; Müntefering H; Wirth S; Hofstra RM; Mulligan L; Eng C; von Deimling A Gut; 2001 May; 48(5):671-5. PubMed ID: 11302967 [TBL] [Abstract][Full Text] [Related]
9. A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Bolk S; Pelet A; Hofstra RM; Angrist M; Salomon R; Croaker D; Buys CH; Lyonnet S; Chakravarti A Proc Natl Acad Sci U S A; 2000 Jan; 97(1):268-73. PubMed ID: 10618407 [TBL] [Abstract][Full Text] [Related]
10. [From monogenic to polygenic: model of Hirschsprung disease]. Salomon R; Amiel J; Attié T; Pelet A; Munnich A; Lyonnet S Pathol Biol (Paris); 1998 Nov; 46(9):705-7. PubMed ID: 9885824 [TBL] [Abstract][Full Text] [Related]
11. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Attié T; Pelet A; Edery P; Eng C; Mulligan LM; Amiel J; Boutrand L; Beldjord C; Nihoul-Fékété C; Munnich A Hum Mol Genet; 1995 Aug; 4(8):1381-6. PubMed ID: 7581377 [TBL] [Abstract][Full Text] [Related]
12. Human GFRA1: cloning, mapping, genomic structure, and evaluation as a candidate gene for Hirschsprung disease susceptibility. Angrist M; Jing S; Bolk S; Bentley K; Nallasamy S; Halushka M; Fox GM; Chakravarti A Genomics; 1998 Mar; 48(3):354-62. PubMed ID: 9545641 [TBL] [Abstract][Full Text] [Related]
13. Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. Borrego S; Sáez ME; Ruiz A; Gimm O; López-Alonso M; Antiñolo G; Eng C J Med Genet; 1999 Oct; 36(10):771-4. PubMed ID: 10528857 [TBL] [Abstract][Full Text] [Related]
14. Investigation of germline GFR alpha-1 mutations in Hirschsprung disease. Myers SM; Salomon R; Goessling A; Pelet A; Eng C; von Deimling A; Lyonnet S; Mulligan LM J Med Genet; 1999 Mar; 36(3):217-20. PubMed ID: 10204848 [TBL] [Abstract][Full Text] [Related]
15. Within-gene interaction between c.135 G/A genotypes and RET proto-oncogene germline mutations in HSCR families. Fitze G; Cramer J; Serra A; Schreiber M; Roesner D; Schackert HK Eur J Pediatr Surg; 2003 Jun; 13(3):152-7. PubMed ID: 12939698 [TBL] [Abstract][Full Text] [Related]
16. Mutations of the RET proto-oncogene in Hirschsprung's disease. Edery P; Lyonnet S; Mulligan LM; Pelet A; Dow E; Abel L; Holder S; Nihoul-Fékété C; Ponder BA; Munnich A Nature; 1994 Jan; 367(6461):378-80. PubMed ID: 8114939 [TBL] [Abstract][Full Text] [Related]
17. [Mutations of RET proto-oncogene in Hirschsprung disease]. Lyonnet S; Edery P; Mulligan LM; Pelet A; Dow E; Abel L; Holder S; Nihoul-Fékéte C; Ponder BA; Munnich A C R Acad Sci III; 1994 Apr; 317(4):358-62. PubMed ID: 8000915 [TBL] [Abstract][Full Text] [Related]
18. A rare haplotype of the RET proto-oncogene is a risk-modifying allele in hirschsprung disease. Griseri P; Pesce B; Patrone G; Osinga J; Puppo F; Sancandi M; Hofstra R; Romeo G; Ravazzolo R; Devoto M; Ceccherini I Am J Hum Genet; 2002 Oct; 71(4):969-74. PubMed ID: 12214285 [TBL] [Abstract][Full Text] [Related]
19. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease. Ivanchuk SM; Myers SM; Eng C; Mulligan LM Hum Mol Genet; 1996 Dec; 5(12):2023-6. PubMed ID: 8968758 [TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Angrist M; Bolk S; Thiel B; Puffenberger EG; Hofstra RM; Buys CH; Cass DT; Chakravarti A Hum Mol Genet; 1995 May; 4(5):821-30. PubMed ID: 7633441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]